Close
Digital Health & Ai Innovation summit 2026
APE 2026

Content Team HHMGlobal

Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth

The U.S. Food and Drug Administration's (FDA) recent approval of Zarxio (filgrastim-sndz) -- the first biosimilar product approved in the United States -- points...

EyePromise® Eye Vitamins to Support Healthy Vision Month

The month of May is designated as Healthy Vision Month by the National Eye Institute (NEI). To celebrate healthy vision, EyePromise has created a...

Life Sciences Hub Takes Shape in Windsor-Essex, Ontario Canada

Today, the WindsorEssex Economic Development Corporation and Hôtel-Dieu Grace Healthcare joined forces by signing a memorandum of understanding (MOU) to officially launch the cross...

New Study Reveals America’s Fear of Aging

According to a new Aegis Living Study on Attitudes Toward Aging, adults of all generations are equally as likely to worry about what will...

Share the road: Look, listen to stay wreck-less and injury free this summer

Motorcyclists will be the first to tell you, it's the thrill of the ride and the wind in their hair that keeps them riding....

Visus Technology, Inc. appoints its Chief Technology Officer

Visus Technology, Inc. ("Visus" or "VisusTech"), announces the appointment of its Chief Technology Officer, Attila A. Priplata, PhD, effective May 22, 2015. The word...

Kalorama: Top Companies Dominate Cardiac Defibrillator Market

The leading companies in the cardiac defibrillator segment of the $13 billion global cardiac rhythm management device market dominate their competition, according to Kalorama...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »